Latest Regulatory Scrutiny News

Silk Logistics Holdings has announced a court-ordered postponement of the Scheme Meeting for its acquisition by DP World Australia, delaying shareholder decisions and the acquisition timeline.

PointsBet Holdings has secured Foreign Investment Review Board approval for MIXI Australia's proposed full acquisition, marking a key regulatory milestone in the takeover process.

ASX Limited’s 2025 Investor Forum reveals steady progress on its five-year strategy, highlighting technology modernization, operational risk management, and a focus on data-driven growth. The exchange outlines capital expenditure plans and expense controls aimed at sustaining shareholder value amid evolving market demands.

Vinyl Group Ltd has had its trading suspension lifted following a Federal Court decision related to its previous non-compliance with cleansing notice requirements.

Monash IVF has disclosed a significant embryo transfer error at its Clayton laboratory, prompting an internal investigation and expanded independent review. The company is implementing new safeguards while maintaining its profit outlook.

Codeifai Limited has addressed ASX concerns over unusual trading activity, confirming awareness of undisclosed information and releasing a status update on proposed transactions.

The Takeovers Panel has imposed interim orders restricting key parties from dealing with shares in Mayfield Childcare Limited, signaling regulatory scrutiny over the company's affairs.

Evolution Energy Minerals (EV1) addresses ASX queries over recent share price and volume spikes, attributing the activity to a subsidiary’s new US$2 million term sheet while confirming no undisclosed information.

Inoviq Ltd's trading suspension has been lifted following new disclosures, but the ASX continues to investigate the company's compliance with listing rules.

Manuka Resources’ Taranaki VTM Project has advanced through a critical regulatory checkpoint, with no competing applications or appeals standing in its way, moving closer to expert panel determination.

Chorus Limited’s 2024 fibre regulatory report reveals a stable $5.9 billion asset base and revenue close to the maximum allowed, with a $153.5 million wash-up balance carried forward.

Wellnex Life Limited has had its trading suspension lifted following its response to ASX queries related to a recent shareholder letter, reopening market access to its shares.